|
Market Cap (26-May) $246,698,016 (417th) |
Close (30-Jun) $1.23 |
Volume (30-Jun) 249,053 |
Shortsold (5-May) 39,772 (0.02%) (495th) |
|
52w High $2.09 |
52w Low $0.92 |
P/E - |
EPS -0.05 |
RAC released this announcement to the ASX on 9 November 2021, 9:22. The announcement is marked as price sensitive, and is 4 page(s) in length and 121.33kb in size.
You can view all announcements from RAC and see how they appear on a price chart on the announcements page.
At the date of this announcement, RAC was 0.013% short sold according to ASIC data. It was ranked the 582nd most shorted stock on the ASX. It is now ranked as the 495th most shorted stock on the ASX with 0.023% of total shares short sold as of the latest reported data (05 May 2025).
| Other Recent Announcements from RAC | |
|---|---|
| Notification of cessation of securities - RAC | 29 June 2023, 9:54 |
| Proposed issue of securities - RAC | 29 June 2023, 9:52 |
| Initial Director's Interest Notice | 29 June 2023, 9:46 |
| University of Wollongong R&D Collaboration | 9 November 2021, 9:22 |
| Appendix 3Y - Dr John Cullity | 4 November 2021, 13:17 |
| Companion Diagnostic Study Initiated with UON | 3 November 2021, 9:26 |
| Ethics submission to commence Phase 2 AML EMD Trial | 1 November 2021, 9:22 |
You must be logged in to post a reply.
Race Oncology 